학술논문

Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus.
Document Type
Article
Source
Frontiers in Endocrinology; 2023, p1-9, 9p
Subject
TYPE 1 diabetes
IMMUNE checkpoint inhibitors
DRUG side effects
CANCER treatment
CANCER patients
Language
ISSN
16642392
Abstract
Copyright of Frontiers in Endocrinology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)